The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Bacil Pharma Ltd

Bacil Pharma Ltd

BSE 524516 · NSE BACPHAR · ISIN INE711D01018 · Group X · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹11.43

-1.64%

BSE close, 28 August 2026

Market cap

₹16.41 cr

1.4 cr shares · Micro cap

Free float

₹16.41 cr

as published

P/E · P/B

24.9× · 9.69×

EPS ₹0.46 · BV ₹1.18

FY25-26 rev / PAT

— / 1.56

₹ cr, as filed

Filings, window

13

4 selected · 31%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹10.65 52-WK HIGH ₹61.80 ₹11.43 2% of range
Against 52-week high-81.5%
Against 52-week low+7.3%
Day change-1.64%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹0.46
Price / earnings24.85×
Price / book9.69×
Book value — derived, price ÷ P/B₹1.18
Return on equity38.83%
Operating margin—
Net margin—

Consistency check

P/B ÷ P/E, which must equal ROE
38.99%
ROE as published
38.83%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q — -0.02 0.22 — —
Mar-26 · Q — 0.62 0.44 — —
FY25-26 — 1.56 1.11 — —

Quarter on quarter

Net profit, quarter on quarter
-103.2%

Disclosure profile 13 filings in the window

0 median 17.0 p75 · 25 sector max 52 13 34th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome2
KMP1
Results1
Selected sub-total4
Procedural
Board Meeting4
AGM / EGM2
General2
Annual Report1
Procedural sub-total9
Total13

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

13 filings · 4 selected · busiest 2026-08-12 and 2026-08-25

Filing rhythm · the twelve most recent

2026-08-062026-10-08

SelectedProcedural

Filings

13 in the window · 19 earlier on record

  1. 8 October 2026 ·

    KMP

    Resignation of Company Secretary / Compliance Officer

    Intimation for resignation of Company Secretary

    Company Update / Resignation of Company Secretary / Compliance Officer View filing →

  2. 5 October 2026 ·

    Board Meeting

    Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Wednesday, 14Th October, 2026

    Bacil Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results ....

    Board Meeting / Board Meeting View filing →

  3. 24 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scrutinizers Report for the Annual General Meeting of the Company for FY 2025-2026

    AGM/EGM / AGM View filing →

  4. 23 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome/Proceeding of Annual General Meeting of the Company

    AGM/EGM / AGM View filing →

  5. 31 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report for the Financial Year 2025-2026

    Others / Reg. 34 (1) Annual Report View filing →

  6. 26 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Bacil Pharma Limited ("The Company") Will Be Held On 29Th August, 2026

    Bacil Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2026 ,inter alia, to consider and approve Discussion on Notice for 39th ....

    Board Meeting / Board Meeting View filing →

  7. 25 August 2026 ·

    General

    Appointment Of Director

    Appointment of Director

    Company Update / General View filing →

  8. 25 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th August, 2026

    Outcome of Board Meeting held on 25th August, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  9. 17 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 25Th August 2026

    Bacil Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2026 ,inter alia, to consider and approve Board meeting to be held on 25th ....

    Board Meeting / Board Meeting View filing →

  10. 12 August 2026 ·

    Results

    Un-Audited Financial Results For The Quarter Ended 30Th June, 2026

    Un-audited Financial Results for the Quarter Ended 30th June, 2026

    Result / Financial Results View filing →

  11. 12 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August, 2026

    Outcome of Board Meeting held on 12th August, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  12. 6 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12Th August 2026

    Bacil Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting for ....

    Board Meeting / Board Meeting View filing →

  13. 28 July 2026 ·

    General

    Announcement Under Regulation 30, LODR

    Regarding the incorporation of a wholly owned subsidiary of the company named Bacil Research & Development Private Limited.

    Company Update / General View filing →

RSS feed for Bacil Pharma Ltd · the 50 most recent filings